Cargando…
Clinical trial transparency in the Americas: the need to coordinate regulatory spheres
Numerous initiatives have contributed to health data transparency in the Americas, but further coordinated effort is needed to ensure the reliability of research for health, argue Trudo Lemmens and Carlos Herrera Vacaflor
Autores principales: | Lemmens, Trudo, Vacaflor, Carlos Herrera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046252/ https://www.ncbi.nlm.nih.gov/pubmed/30012844 http://dx.doi.org/10.1136/bmj.k2493 |
Ejemplares similares
-
Keeping the GINA in the bottle: assessing the current need for genetic non-discrimination legislation in Canada
por: Pullman, Daryl, et al.
Publicado: (2010) -
Governance of conflicts of interest in postmarketing surveillance research and the Canadian Drug Safety and Effectiveness Network
por: Ferris, Lorraine E, et al.
Publicado: (2010) -
Promoting high quality research into priority health needs in Latin America and Caribbean
por: Zicker, Fabio, et al.
Publicado: (2018) -
The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good
por: Bardosh, Kevin, et al.
Publicado: (2022) -
The need for standardised methods of data collection, sharing of data and agency coordination in humanitarian settings
por: Shalash, Aisha, et al.
Publicado: (2022)